Abstract
Isoflavones also possess non-hormonal activity that is associated with the inhibition of cancer cell growth. However, their role in breast cancer has become controversial as, despite possible beneficial effects, some data from in-vitro and animal studies suggest that isoflavones, especially genistein (the aglycone of the main soybean), may stimulate the growth of oestrogen-sensitive tumours.
Original language | English |
---|---|
Pages (from-to) | 17-19 |
Number of pages | 3 |
Journal | Pharmacy News |
Issue number | 12/APR. |
Publication status | Published - 12 Apr 2007 |